Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H2 2018
|
MACK |
|
Phase 2 Results |
Oncology |
Orphan Drug |
|
H2 2018
|
MACK |
|
Phase 2 Results |
Oncology |
Fast Track |
|
H1 2018
|
CNAT |
|
Phase 2b Results |
Other |
Fast Track, Orphan Drug |
|
H1 2018
|
RETA |
|
Phase 3 Results |
Cardiovascular |
Orphan Drug |
|
Q1 2018
|
GLMD |
|
Phase 2b Results |
Other |
None |
|
Q1 2018
|
AVEO |
|
Phase 3 Results |
Oncology |
None |
|
Q1 2018
|
PRTA |
|
Phase 2b Results |
Endocrine |
Fast Track |
|
Q1 2018
|
VTVT |
|
Phase 2b Results |
Neurology |
Fast Track, Special Protocol Assessment |
|
Q1 2018
|
ALNY |
|
Phase 3 Results |
Other |
Orphan Drug |
|
H2 2017
|
ARDX |
|
Phase 3 Results |
Other |
None |
|